Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

ReWalk Robotics to Report Second Quarter 2018 Financial Results on August 14, 2018
By: Nasdaq / GlobeNewswire - 10 Aug 2018Back to overview list

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 10, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018, before the U.S. financial markets open.   

Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will host a conference call to discuss the results as follows:

Time8:30 a.m. EDT
Toll free (U.S.)(844) 423-9889
International(716) 247-5804
Israel18 09 31 53 62
Webcast (live and replay)www.rewalk.com under the ‘Investors’ section.

A replay of the conference call will be available for two weeks after the call's completion by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (International).  The conference ID for the replay is 4694309. The archived webcast will be available for 30 days via the aforementioned URL.  

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.  ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.

ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.

Contact:
Lisa Wilson
In-Site Communications, Inc.
Investor Relations
T: (212) 452-2793
E: lwilson@insitecony.com

Related companies:Argo Medical Technologies
Copyright 2018 Nasdaq / GlobeNewswire Back to overview list
to the top ↑